Literature DB >> 35930138

Cistanche Deserticola for Regulation of Bone Metabolism: Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis.

Cheng Wang1, Feng Li1, Yang Li1, Hui Feng1, Min-Wei Zhao1, Peng-Fei Tu2, Hua Tian3.   

Abstract

Osteoporosis is a generalized disease of bone that leads to a loss of bone density and bone mass, destruction of bone microstructure, increased brittleness and therefore fracture. At present, the main treatment of Western medicine is drug therapy such as bisphosphonates, calcitriol, vitamin D, etc. However, long-term use of these drugs may bring some adverse reactions. Chinese herbal medicine Cistanche deserticola could regulate bone metabolism by promoting osteoblast activity and inhibiting osteoclast activity with low toxicity and adverse reactions. Therefore, Cistanche deserticola has attracted increasing attention for its efficacy in the prevention and treatment of osteoporosis in recent years. Here we present a literature review of the molecular pathways involved in osteoporosis and the effects of Cistanche deserticola on bone metabolism. Our objective is to clarify the mechanism of Cistanche deserticola in the treatment of osteoporosis.
© 2022. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chinese medicine; Cistanche deserticola; bone metabolism; osteoporosis

Year:  2022        PMID: 35930138     DOI: 10.1007/s11655-022-3518-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   2.626


  40 in total

1.  The quest for evidence for calcium requirements for bone during pregnancy and lactation.

Authors:  Connie M Weaver
Journal:  Am J Clin Nutr       Date:  2019-01-01       Impact factor: 7.045

2.  Bone Resorption Activity in Mature Osteoclasts.

Authors:  Takeshi Kiyoi
Journal:  Methods Mol Biol       Date:  2018

3.  Postmenopausal Osteoporosis.

Authors:  Angela M Cheung; Alexandra Papaioannou; Suzanne Morin
Journal:  N Engl J Med       Date:  2016-05-26       Impact factor: 91.245

4.  Prevention of fractures in patients with osteoporosis.

Authors:  Serge Livio Ferrari
Journal:  Lancet       Date:  2017-11-09       Impact factor: 79.321

5.  Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial.

Authors:  Lee Shepstone; Elizabeth Lenaghan; Cyrus Cooper; Shane Clarke; Rebekah Fong-Soe-Khioe; Richard Fordham; Neil Gittoes; Ian Harvey; Nick Harvey; Alison Heawood; Richard Holland; Amanda Howe; John Kanis; Tarnya Marshall; Terence O'Neill; Tim Peters; Niamh Redmond; David Torgerson; David Turner; Eugene McCloskey
Journal:  Lancet       Date:  2017-12-16       Impact factor: 79.321

Review 6.  Clinical Practice. Postmenopausal Osteoporosis.

Authors:  Dennis M Black; Clifford J Rosen
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

Review 7.  Osteoporosis.

Authors:  Juliet E Compston; Michael R McClung; William D Leslie
Journal:  Lancet       Date:  2019-01-26       Impact factor: 79.321

Review 8.  Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.

Authors:  Benjamin Z Leder
Journal:  Curr Osteoporos Rep       Date:  2017-04       Impact factor: 5.096

Review 9.  Postmenopausal osteoporosis: Assessment and management.

Authors:  René Rizzoli
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-09-22       Impact factor: 4.690

10.  Protective Effects of Controlled Mechanical Loading of Bone in C57BL6/J Mice Subject to Disuse.

Authors:  Alex DeLong; Michael A Friedman; Scott M Tucker; Andrew R Krause; Allen Kunselman; Henry J Donahue; Gregory S Lewis
Journal:  JBMR Plus       Date:  2019-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.